1.94
price down icon1.02%   -0.02
after-market Handel nachbörslich: 1.76 -0.18 -9.28%
loading

Finanzdaten der Biocardia Inc-Aktie (BCDA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - 0.003
Selling, General, and Administrative
42.89%
0.683
1.196 - - -
Costs And Expenses
24.76%
2.051
2.726 2.321 1.756 1.652
Operating Income/Loss
24.76%
-2.051
-2.726 -2.321 -1.756 -1.649
Nonoperating Income/Loss
85.71%
0.002
0.014 0.025 0.019 0.003
Income/Loss From Continuing Operations Before Tax
24.37%
-2.051
-2.712 -2.321 -1.756 -1.646
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
24.45%
-2.049
-2.712 -2.296 -1.737 -1.646
Net Income/Loss
24.45%
-2.049
-2.712 -2.296 -1.737 -1.646
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
9.15%
5.0597
4.6358 0.6146 2.8275 1.8771
Basic Earnings Per Share
32.20%
-0.40
-0.59 -0.25 -0.61 -0.88
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.78
price up icon 0.98%
$84.84
price up icon 1.00%
$24.80
price down icon 8.06%
$103.01
price down icon 1.70%
$134.53
price up icon 1.79%
biotechnology ONC
$300.14
price down icon 2.84%
Kapitalisierung:     |  Volumen (24h):